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Purpose: In previous studies, the aqueous extract of Combretum molle was shown to inhibit 
disturbances of breathing induced by acetylcholine. The aim of this study was to elucidate the 
mechanism of this inhibition. 
Methods: The aqueous extract of Combretum molle and an anti-asthmatic, salbutamol 
(reference), were tested at varying concentrations for their inhibitory effects on breathing. 
Acetylcholinesterase (AChE) was extracted from rabbit duodenum and its activity determined 
by Ellman’s assay using acethylthiocholine iodide (ACTH) as substrate. The rate of hydrolysis 
of acetylcholinesterase was spectrophotometrically monitored at 412 nm.  
Results: The results indicate that in the presence of C. molle extract, a considerable 
reduction in the variation of breathing amplitudes occurred. Furthermore, the extract probably 
contains anti-AChE substances. C. molle exerted non-competitive inhibition of 
acetylcholinesterase with Michaelis-Menten constant (KM) of 192 µM and velocity at maximal 
concentration of substrate (Vmax) of 4444 µM/min. 
Conclusion: These results support the use of C. molle leaf in the Pharmacopoeia of Ivory 
Coast as an anti-asthmatic, in view of its inhibitory effect on breathing disturbances. 
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INTRODUCTION 
 
In Ivory Coast, 18 % of the population is 
asthmatic [1]. Asthma attacks result from the 
contractions of the peripheral bronchi. These 
bronchoconstrictions are accompanied by 
wheezing and coughing. Several 
antiasthmatic agents, including salbutamol, 
are used to inhibit bronchoconstrictions [2]. 
Salbutamol is an alkaloid which dilates the 
bronchi. 
 
The aqueous extract of C. molle is often used 
to treat cough in traditional medical practice 
in northern Ivory Coast [3]. We previously 
studied the inhibitory effects of this plant 
material on cough in which it was found that 
the leaf of C. molle has antitussive activity [4]. 
It is also used in Ethiopia to treat infections 
caused by the trypanosome, Brucei 
rhodesiense, and Leishmania donovani [5]. It 
is known that bronchoconstriction is at the 
origin of asthma and also reduces breathing 
amplitudes. The present study was 
undertaken to evaluate the inhibitory effect of 
the aqueous extract of C. molle leaf on 
breathing disturbances. The effect of this 
extract on the catalytic activity of the 
acetylcholinesterase extracted from 






All the chemicals used were of analytical 
grade and obtained from either Sigma 
Chemical Co., St Louis, MQ, USA, Aldrich 
Chemical Co., Steineheim, Germany, or 




Rabbits, with a mean weight of 1.3 kg, were 
used in the study. All the animals were kept 
in an animal house at 60 %RH and 25 °C in a 
12-hour light/dark cycle. They were cared for 
and treated according to the principles for the 
care and use of laboratory animals. Ethical 
approval was given by the institutional 
committee for animal studies of University of 
Cocody-Abidjan (Ivory Coast).  
 
Preparation of aqueous extract 
 
The plant material was identified by Professor 
Ake-Assi of the National Floristic Center, 
University-Abidjan, Ivory Coast, and a 
voucher specimen no. 6129 was in kept in a 
herbarium (C. molle; Ferkessedougou, 19/10-
62) of the institution. Following harvesting of 
the leaves of the plant, they were dried in the 
open air at room temperature until they 
attained constant weight. The dried leaves 
were powdered in a mortar and about 10 g of 
the powder was extracted with 2 L of distilled 
water for 24 h on a hot plate. The mixture 
was filtered over a cheese cloth, cotton wool 
and Whatman filter paper No.1, respectively. 
The filtrate obtained was concentrated over a 




The tests were carried out in vivo in rabbits 
which were anaesthetized by intraperitoneal 
administration of 92 mg/kg of ethylurethane. 
The animals (30) were divided into 5 groups 
of six animals each. Group 1 served as 
control and did not receive any treatment 
while Group 2 received acetylcholine (ACH) 
and then the extract. Group 3 received ACH 
alone while Group 4 received ACH (7 µg/kg) 
and then the reference, salbutamol (0.3 
µg/kg). Group 5 animals received ACH (7 
µg/kg) and also the extract together with 
calcium (0.9 %). 
 
Intubation of jugular vein and trachea 
 
The rabbits were anaesthetized and the 
jugular vein was cleaned with 0.9 % NaCl 
and clamped. Another node was made below 
it. A catheter was introduced into the vein and 
attached using the second node. Another 
catheter was introduced into the trachea and 
connected to the respiratory device. Using 
this catheter, the variation in amplitude, 
expressed as a percentage, was measured 
using a kymograph rotating at 0.8 mm/s. The 
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plant extract was injected into the jugular 
vein. 
 
Induction of breathing disturbances 
 
The jugular vein was used because it 
provided easy access to the lung. Breathing 
disturbances were initiated with acetylcholine. 
Administration of increasing concentrations of 
salbutamol and the extract was combined 
with that of acetylcholine in order to counter 





Enzyme extraction was performed according 
to the method of Bui and Ochillo [6]. A length 
of lung tissue weighing 1 g was added to 50 
ml of phosphate buffer and crushed with a 
mortar (Ultra Turax T25). The homogenate 
was centrifuged and the supernatant used for 
enzyme assays. Acetylcholinesterase activity 
was determined spectrophotometrically by 
Ellman’s assay [7]. To each cuvette was 
added 5,5’- dithio-bis-(2-nitro) benzoic acid 
(DTNB) (100 µL of 0.01 M DTNB in 50 mM 
potassium phosphate buffer, pH 7.8) followed 
by the addition of 25 µL of acetylthiocholine 
(ATCh) of varying concentration in 50 mM 
potassium phosphate buffer, pH 7.8. The 
enzymatic reaction was initiated at 25 °C by 
the addition of enzyme (75 µL of 
homogenate, appropriately diluted in 50 mM 
potassium phosphate buffer, pH 7.8), and the 
absorbance change was monitored at 412 
nm with a spectrophotometer (Alresa, 
Barcelona, Spain). 
 
Enzyme kinetic analysis 
 
To determine the enzyme kinetics of the 
aqueous extract of C.molle, kinetic analysis 
of the lung AChE solution in the presence of 
the extract was performed. The mixture of 
enzyme and extract was incubated at 37 
o
C 
for 5 min, and then the substrate, in varying 
concentrations, was added and immediately 
stirred for 10 s. The change of absorbance at 
412 nm was monitored and the initial velocity 
(dA/min) of the reaction was calculated from 
the absorbance change. The kinetics of 
AChE in the presence of C. molle was 
determined by the Lineweaver-Burk (LB) plot. 
The LB plot represents reciprocal velocities 
vs. the reciprocal substrate concentration of 
the control (without inhibitor) and the series of 




The results were expressed as mean ± 
standard error of mean (SEM). Statistical 
differences between the treated and the 
control groups were evaluated by ANOVA 
and Students-Newman-Keuls post-hoc test. 
For each analysis, p values under 0.05 were 
considered to be statistically significant. 





Inhibitory effect of Combretum molle 
extract 
 
Fig 1 shows the effect of the extract on 
breathing amplitude. Acetylcholine (ACH), 
which served as control, significantly (p < 
0.05) affected breathing, producing a 
variation of breathing amplitude of –47.67 ± 
5%. This value therefore served as the 
control for the test. The combination of the 
extract and ACH, however, reduced the 
variation in breathing amplitude. Furthermore, 
the latency time of breathing disturbances 
was 6.1 s for ACH alone but when it was 
combined with the extract, latency time 
increased progressively. 
 
Also, the addition of the extract reduced the 
duration of the breathing disturbances from 
77 s which was the value for ACH alone. 
Salbutamol gave a short latency time of the 
breathing disturbances compared to ACH. At 
a dose of 0.3 µg/kg body weight, salbutamol 
showed a reduction in the duration of 
breathing disturbances as much as the 
extract.   
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Figure 1: Variation in breathing amplitude in the 
presence of control (ACH, ■);  salbutamol (▲); 
and C .molle extract.(▼)  (n = 6)  
 
Inhibition of calcium-induced broncho-
constriction by the extract 
 
Table 1 shows the inhibition of the effect of 
calcium by the extract. Injection of calcium 
produced an amplitude variation of – 42.6 % 
in bronchoconstriction but there was no 
significant modification of the level of 
respiratory frequency. However, co-
administration of calcium with the extract 
significantly reduced breathing amplitude 
variation from –28.6±4.0 to -10.5±6.5 %. A 
significant reduction of the duration of 
breathing disturbances induced by 
acetylcholine was also effected by the 
extract.  
 
Table 1: Effect of combined C. molle 










(cycles/min) 71±4 69±4 68±4 
V (%)  0 -28.6±3.7 -10.5±6.5** 
TL (s) 0 3.5±0,7 9.1±2.0*** 
TB (s) 0 64±7 32±2* 
 
*p < 0.05; **p < 0.01;  *** p < 0.001 (compared to  Ca
2+ 
control, n = 6); Blank = no treatment 
 
Effect of the extract on the hydrolytic 
action of AChE 
 
The kinetic analysis of AChE inhibition by the 
extract, which is based on the Lineweaver 
and Burk plot [9], is shown in Figure 2. The 
plot, in which the lines obtained cross y-axis 
and the x-coordinates at two distinct points 
corresponding to 1/Vmax and -1/KM led to the 
determination of Vmax and KM, respectively. 
The KM and Vmax values for AChE alone 
were 192 µM and 5128 µM/min, respectively, 
but on addition of the extract, the 
corresponding values were: KM (192 µM) and 
Vmax (4444 µM/min). Thus, the extract 
inhibited AChE in a non-competitive manner. 
















Figure 2: Lineweaver-Burk (LB) plot of initial 
enzyme velocity (V) against the acetylthiocholine 
iodide concentration ([S]) in the presence (□) and 





Disturbances in breathing result from 
contractions of the bronchial smooth muscle 
in breathing pathways [10]. These 
contractions can be induced by several 
agents. In our study, acetylcholine was used 
to induce bronchial constrictions because it is 
probably at the origin of bronchoconstrictions 
and hence breathing disturbances [11]. It is 
known that acetylcholine binds to muscarinic 
receptors to induce a reduction in breathing 
amplitude [12]. 
 
In the present work, C. molle extract reduced 
the variation in breathing amplitude induced 
by acetylcholine. It is known that calcium is 
essential for the contraction of bronchial 
smooth muscles [13]. The plant extract 
inhibited the effects induced by calcium and 
acetylcholine. This inhibition could have been 
brought about by either or both of the 
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following mechanisms. First, the extract 
prevented acetylcholine from binding to the 
receptors of the bronchial muscles. Second, 
the extract exerted an anti-calcium effect by 
preventing calcium from entering the cells of 
the respiratory smooth muscles. 
 
Salbutamol [2] – a well-known bronchodilator 
- was used as a reference standard in this 
study. It is also an effective antiasthmatic 
[14]. The results indicate that both salbutamol 
and the extract inhibited the bronchial 
contractions induced by acetylcholine in a 
similar manner. Furthermore, in view of its 
anti-calcium effect in bronchial muscle, the 
extract probably also manifests calcium 
channel-blocking properties. It is noteworthy 
that the extract inhibited AChE; this effect, to 
the best of our knowledge, is being reported 




The aqueous leaf extract of C. molle inhibited 
breathing disturbances induced in rats by 
acetylcholine just like salbutamol. The extract 
also showed anticholinesterase activity and 
probably calcium blocking properties as well, 
thus indicating the need for more research to 
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